Evidence map›Paper›PMID 33004610›Full record

Observational studySexually transmitted infections2021

Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa.

Dorothy Chiwoniso Nyemba, Andrew Medina-Marino, Remco P H Peters, Jeffrey D Klausner, Phuti Ngwepe, Landon Myer, Leigh Francis Johnson, Dvora Joseph Davey

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Sexually transmitted infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Effect of antenatalSexually transmitted infections · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Dorothy Chiwoniso NyembaDivision of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa dorothy.nyemba@uct.ac.za.ORCID 0000-0002-3391-3223
Andrew Medina-MarinoDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Remco P H PetersResearch Unit, Foundation for Professional Development, East London, South Africa.
Jeffrey D KlausnerDepartment of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
Phuti NgwepeResearch Unit, Foundation for Professional Development, East London, South Africa.
Landon MyerDivision of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Leigh Francis JohnsonCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Dvora Joseph DaveyDivision of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZADesmond Tutu HIV Foundation · ZAFoundation for Professional Development · ZAMaastricht University Medical Centre · NLUniversity of California, Los Angeles · US

Funding

Clinical Study of STI Screening to Prevent Adverse Birth and Newborn OutcomesR01AI149339 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KLAUSNER, JEFFREY DAVID, MEDINA-MARINO, ANDREW · 2020 to 2024
$4.3M
Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South AfricaR01HD106862 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DVORA Leah JOSEPH DAVEY · 2021 to 2026
$2.7M
Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)R01MH116771 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH, MYER, BENJAMIN LANDON · 2018 to 2022
$2.5M
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South AfricaK01TW011187 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH · 2018 to 2022
$698k
Pilot Study of STI Screening and Treatment for PMTCTR21HD084274 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KLAUSNER, JEFFREY DAVID, MEDINA-MARINO, ANDREW · 2015 to 2016
$352k
FIC NIH HHS K01 TW011187NIAID NIH HHS R01 AI149339NICHD NIH HHS R01 HD106862NICHD NIH HHS R21 HD084274NIMH NIH HHS R01 MH116771PEPFAR
6 · The paper itself

Abstract

objectiveSTIs during pregnancy increase adverse pregnancy and birth outcomes and may increase HIV risk. STI syndromic management is standard of care in South Africa. Our study evaluated the prevalence and incidence of STIs in pregnant women and the associated risk factors.

methodsWe combined data from two prospective observational studies of pregnant women enrolled while attending their first antenatal clinic (ANC) visit in Tshwane District and Cape Town. Women ≥18 years were tested at first ANC visit and at their first postpartum visit for

resultsWe enrolled 669 pregnant women, 64% (n=427) from Tshwane District and 36% (n=242) from Cape Town; 80% (n=534) were women living with HIV (WLHIV) and 20% (n=135) without HIV. At enrolment, 37% (n=250) were diagnosed with at least one STI, of which 76% (n=190) were asymptomatic. STI prevalence was 40% (n=213) in WLHIV and 27% (n=37) in women without HIV (p=0.01). Baseline STI infection was associated with younger age (OR=0.95 per year, 95% CI 0.92 to 0.98), higher gestational age (adjusted OR (aOR)=1.03 per week, 95% CI 1.00 to 1.05), single relationship status (aOR=1.53, 95% CI 1.09 to 2.15) and HIV status (aOR=1.86, 95% CI 1.17 to 2.95). Of 419 participants with no STI at baseline, 21 had an incident STI during follow-up, with a mean follow-up time of 140 days. The incidence rate of STI during pregnancy and early post partum was 15 infections per 100 women-years (95% CI 9 to 23). Younger age was associated with STI incidence.

conclusionOur study shows high prevalence and incidence of STIs in pregnancy, especially in WLHIV, demonstrating the need for STI screening in ANC to prevent adverse pregnancy and birth outcomes. Most STI cases were asymptomatic and would have gone untreated with syndromic management. Aetiological STI screening is urgently needed to reduce the burden of STIs in pregnancy.

Indexed as

PregnancyFemaleHIV InfectionsHumansIncidencePregnancy Complications, InfectiousPrevalenceRisk FactorsSexually Transmitted DiseasesSouth AfricaChlamydia trachomatisHIVNeisseria gonorrhoeaesyndromic managementTrichomonas

Identifiers

PMID33004610
PMCPMC8012394
OpenAlexW3090190237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.